Literature DB >> 12915075

Epidemiology and treatment of Parkinson's disease in India.

Bhim Singhal1, Jimmy Lalkaka, Charu Sankhla.   

Abstract

Parkinson's disease (PD) has a low prevalence in India except in the small Parsi community where Bharucha et al. found a high prevalence. Although early onset PD and familial cases have been described from India, no genetic mutations have as yet been identified. PD has been known in India since ancient days and the powder of Mucuna Pruriens seeds was used for its treatment. The present day management of PD in India is similar to that in the other countries. Unfortunately, lack of awareness, limitation of human resources and cost factors deny the benefits of therapy to many patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915075     DOI: 10.1016/s1353-8020(03)00024-5

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection.

Authors:  Amala Soumyanath; Tanya Denne; Amie Hiller; Shaila Ramachandran; Lynne Shinto
Journal:  J Altern Complement Med       Date:  2017-09-18       Impact factor: 2.579

Review 2.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

3.  The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate.

Authors:  Christopher A Lieu; Kala Venkiteswaran; Timothy P Gilmour; Anand N Rao; Andrew C Petticoffer; Erin V Gilbert; Milind Deogaonkar; Bala V Manyam; Thyagarajan Subramanian
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-10       Impact factor: 2.629

Review 4.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

5.  Second World Ayurveda Congress (Theme: Ayurveda for the Future)-Inaugural Address: Part II.

Authors:  R A Mashelkar
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

Review 6.  Cell based therapies in Parkinson's Disease.

Authors:  Madhuri Behari; Kapil Kumar Singhal
Journal:  Ann Neurosci       Date:  2011-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.